CEDRIC-HIV: la checklist per gli studi sulla resistenza ai farmaci anti-HIV
Epidemiol Prev
.
2024 Jan-Feb;48(1):3.
doi: 10.19191/EP24.1.A702.012.
Authors
Emanuele Blasioli
1
,
Lawrence Mbuagbaw
2
3
4
5
6
7
,
Joseph Fokam
8
9
10
,
Maria Mercedes Santoro
11
Affiliations
1
DeGroote School of Business, McMaster University, Hamilton (ON, Canada); blasiole@mcmaster.ca.
2
Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton (ON, Canada).
3
Department of Anesthesia, McMaster University, Hamilton (ON, Canada).
4
Department of Pediatrics, McMaster University, Hamilton (ON, Canada).
5
Biostatistics Unit, Father Sean O'Sullivan Research Centre, St Joseph's Healthcare, Hamilton (ON, Canada).
6
Centre for Development of Best Practices in Health (CDBPH), Yaoundé Central Hospital, Yaoundé (Cameroon).
7
Department of Global Health, Stellenbosch University, Cape Town (South Africa).
8
Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé (Cameroon).
9
Faculty of Health Science, University of Buea, Buea (Cameroon).
10
National HIV Drug Resistance Working Group, Ministry of Public Health, Yaoundé (Cameroon).
11
Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome (Italy).
PMID:
38482779
DOI:
10.19191/EP24.1.A702.012
No abstract available
Publication types
Letter
MeSH terms
Checklist*
HIV Infections* / epidemiology
HIV Infections* / prevention & control
Humans
Italy